Houston (1)

Newly Diagnosed Primary Amyloidosis (1)

Recurrent Primary Amyloidosis (1)

Refractory Primary Amyloidosis (1)

Recruiting (1)

phase 1 (1)

M.D. Anderson Cancer Center (1)

Janssen Pharmaceuticals (1)

Takeda (1)

daratumumab (1)

dexamethasone (1)

ixazomib (1)

biological (1)

drug (1)

Other (1)

Interventional (1)

newly diagnosed primary amyloidosis

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Feb 12, 2021